Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Capital Expenditures of -$77.6 million for Q1 2026, down 4.77% year-over-year from -$81.5 million in Q1 2025, and up 25.38% quarter-over-quarter from -$103.9 million in Q4 2025.
Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Capital Expenditures data on file, last reported at -$77.6 million in Q1 2026.
- Capital Expenditures for Q1 2026 came in at -$77.6 million, down 4.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$301.0 million (down 3.12% YoY), and the FY2025 annual result was -$307.1 million, up 5.04% from the prior year.
- Capital Expenditures rose to -$77.6 million in Q1 2026 per STVN's latest filing, from -$103.9 million in the prior quarter.
- Over five years, Capital Expenditures peaked at -$40.7 million in Q3 2022 and troughed at -$142.9 million in Q3 2023.
- A 5-year average of -$83.5 million and a median of -$77.6 million in 2026 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures tumbled 250.89% in 2023, then surged 65.84% in 2024.
- A 5-year view of Capital Expenditures shows it stood at -$69.3 million in 2022, then slipped by 27.36% to -$88.2 million in 2023, then fell by 7.67% to -$95.0 million in 2024, then dropped by 9.42% to -$103.9 million in 2025, then climbed by 25.38% to -$77.6 million in 2026.
- Business Quant data shows STVN's Capital Expenditures at -$77.6 million in Q1 2026, -$103.9 million in Q4 2025, and -$54.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 103.30 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 125.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 33.65 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 26.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 84.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 30.79 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 137.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | -77.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.57 Mn |
| Mar 31, 2026 | -77.57 Mn |
| Dec 31, 2025 | -103.95 Mn |
| Dec 31, 2025 | -103.95 Mn |
| Sep 30, 2025 | -54.26 Mn |
| Sep 30, 2025 | -54.26 Mn |
| Jun 30, 2025 | -65.21 Mn |
| Jun 30, 2025 | -65.21 Mn |
| Mar 31, 2025 | -74.04 Mn |
| Mar 31, 2025 | -74.04 Mn |
| Dec 31, 2024 | -95.00 Mn |
| Dec 31, 2024 | -95.00 Mn |
| Sep 30, 2024 | -48.83 Mn |
| Sep 30, 2024 | -48.83 Mn |
| Jun 30, 2024 | -74.00 Mn |
| Jun 30, 2024 | -74.00 Mn |
| Mar 31, 2024 | -109.22 Mn |
| Mar 31, 2024 | -109.22 Mn |
| Dec 31, 2023 | -88.23 Mn |
| Dec 31, 2023 | -88.23 Mn |